Adam L Peyton

Sofosbuvir and Simeprevir Combination Therapy for HCV Genotype 1 Infection: Results of a Single-Center VA Experience.

L. Jeffers, M. Hernandez, M. Toro, 2016, Gastroenterology & hepatology.

Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities

H. Dvory‐Sobol, S. Ho, D. Brainard, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients

Paul L. Martin, Andres F Carrion, C. O'brien, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Reply

Andres F Carrion, K. Bhamidimarri, J. Gutierrez, 2015 .

Reply: To PMID 25825070.

Andres F Carrion, K. Bhamidimarri, J. Gutierrez, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease.

E. Schiff, D. Roth, C. Levy, 2015, Journal of hepatology.

Primary biliary cirrhosis: therapeutic advances.

C. Levy, F. Czul, Adam L Peyton, 2013, Clinics in liver disease.

Primary Care of Patients with Cirrhosis – Current and Future Challenges

Paul L. Martin, Adam L Peyton, 2014, Current Hepatology Reports.

Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study

S. Bergheanu, T. Hassanein, B. Bacon, 2020, Journal of Hepatology.

Hepatitis C treatment in liver transplant setting

K. Bhamidimarri, Adam L Peyton, 2015, Clinical liver disease.

P0878 : First ribavirin-free sofosbuvir and simeprevir treatment of Hepatitis C genotype 1 patients with severe renal impairment (GFR <30 ml/min or dialysis)

E. Schiff, C. Levy, Paul L. Martin, 2015 .